PubRank

Jason F Okulicz

Author PubWeight™ 24.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med 2013 4.26
2 Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study. AIDS Res Ther 2010 1.63
3 The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry. Blood 2009 1.51
4 Chest pain in a military recruit. South Med J 2008 1.45
5 Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS. PLoS One 2011 1.29
6 Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection. PLoS One 2012 1.22
7 Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN. Epilepsia 2012 1.04
8 Hepatitis B vaccine antibody response and the risk of clinical AIDS or death. PLoS One 2012 0.91
9 Early postseroconversion CD4 cell counts independently predict CD4 cell count recovery in HIV-1-postive subjects receiving antiretroviral therapy. J Acquir Immune Defic Syndr 2011 0.90
10 Is Kaposi's sarcoma occurring at higher CD4 cell counts over the course of the HIV epidemic? AIDS 2010 0.88
11 Rapid deep sequencing of patient-derived HIV with ion semiconductor technology. J Virol Methods 2013 0.85
12 Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort. AIDS Res Ther 2012 0.84
13 Elevated CD8 counts during HAART are associated with HIV virologic treatment failure. J Acquir Immune Defic Syndr 2011 0.84
14 Meropenem-induced vanishing bile duct syndrome. Pharmacotherapy 2010 0.83
15 The VACS index predicts mortality in a young, healthy HIV population starting highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2014 0.81
16 Evaluation of extragenital screening for gonorrhea and chlamydia in HIV-infected active duty Air Force members. MSMR 2014 0.80
17 Race/ethnicity and HAART initiation in a military HIV infected cohort. AIDS Res Ther 2014 0.78
18 Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes. Curr Opin HIV AIDS 2010 0.76
19 Human monocytic ehrlichiosis in a renal transplant patient. Scand J Infect Dis 2006 0.76
20 Prevalence of Post-Treatment Controller Phenotype is Rare in HIV-infected Persons after Stopping Antiretroviral Therapy. J Acquir Immune Defic Syndr 2017 0.75
21 Current perspectives in HIV therapeutics. Ann Allergy Asthma Immunol 2011 0.75
22 Knowledge, attitudes, and beliefs about HIV pre-exposure prophylaxis among US Air Force Health Care Providers. Medicine (Baltimore) 2016 0.75
23 Nontuberculous mycobacterium infection in a burn ICU patient. Burns 2010 0.75
24 Skin tears? Am J Med 2006 0.75
25 Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness. J Med Virol 2011 0.75
26 Successful treatment of severe pneumocystis pneumonia with clindamycin-primaquine in an HIV-negative patient. South Med J 2009 0.75
27 Review of the U.S. military's human immunodeficiency virus program: a legacy of progress and a future of promise. MSMR 2017 0.75
28 Systemic preexposure prophylaxis for HIV: translating clinical data to clinical practice. Ann Pharmacother 2014 0.75
29 Physical fitness characteristics of active duty US Air Force members with HIV infection. Medicine (Baltimore) 2016 0.75
30 Brief report: The epidemiology of herpes simplex virus type 2 infections in a large cohort of HIV-infected patients, 2006-2014. MSMR 2016 0.75